GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $414,000 | +71.8% | 10,824 | +78.8% | 0.01% | -8.3% |
| Q2 2021 | $241,000 | +11.6% | 6,052 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $216,000 | -4.4% | 6,052 | -1.6% | 0.01% | -7.7% |
| Q4 2020 | $226,000 | -19.9% | 6,152 | -17.8% | 0.01% | -31.6% |
| Q3 2020 | $282,000 | -2.4% | 7,482 | +5.6% | 0.02% | -9.5% |
| Q2 2020 | $289,000 | +35.0% | 7,082 | +25.3% | 0.02% | +10.5% |
| Q1 2020 | $214,000 | -19.5% | 5,652 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $266,000 | +3.9% | 5,652 | -5.8% | 0.02% | 0.0% |
| Q3 2019 | $256,000 | +13.3% | 5,997 | +6.1% | 0.02% | +11.8% |
| Q2 2019 | $226,000 | -10.7% | 5,652 | -6.6% | 0.02% | -19.0% |
| Q1 2019 | $253,000 | +9.5% | 6,052 | 0.0% | 0.02% | -4.5% |
| Q4 2018 | $231,000 | -4.9% | 6,052 | 0.0% | 0.02% | +22.2% |
| Q3 2018 | $243,000 | -0.4% | 6,052 | 0.0% | 0.02% | -5.3% |
| Q2 2018 | $244,000 | +3.4% | 6,052 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $236,000 | +9.8% | 6,052 | 0.0% | 0.02% | +11.8% |
| Q4 2017 | $215,000 | -15.4% | 6,052 | -3.4% | 0.02% | -19.0% |
| Q3 2017 | $254,000 | -4.5% | 6,263 | +1.6% | 0.02% | -4.5% |
| Q2 2017 | $266,000 | -8.0% | 6,167 | -10.0% | 0.02% | -12.0% |
| Q1 2017 | $289,000 | +18.9% | 6,853 | +8.6% | 0.02% | +8.7% |
| Q4 2016 | $243,000 | -6.5% | 6,308 | +4.7% | 0.02% | -4.2% |
| Q3 2016 | $260,000 | +2.0% | 6,027 | +2.6% | 0.02% | 0.0% |
| Q2 2016 | $255,000 | +6.2% | 5,877 | -0.5% | 0.02% | 0.0% |
| Q1 2016 | $240,000 | +1.3% | 5,907 | +0.5% | 0.02% | 0.0% |
| Q4 2015 | $237,000 | +4.9% | 5,877 | 0.0% | 0.02% | -4.0% |
| Q3 2015 | $226,000 | +0.4% | 5,877 | +8.9% | 0.02% | +8.7% |
| Q2 2015 | $225,000 | -9.6% | 5,399 | 0.0% | 0.02% | -8.0% |
| Q1 2015 | $249,000 | +9.2% | 5,399 | +1.1% | 0.02% | +8.7% |
| Q4 2014 | $228,000 | -7.3% | 5,341 | 0.0% | 0.02% | -8.0% |
| Q3 2014 | $246,000 | -19.9% | 5,341 | -7.0% | 0.02% | -19.4% |
| Q2 2014 | $307,000 | +3.4% | 5,741 | +3.1% | 0.03% | -8.8% |
| Q1 2014 | $297,000 | 0.0% | 5,567 | 0.0% | 0.03% | -8.1% |
| Q4 2013 | $297,000 | +6.5% | 5,567 | 0.0% | 0.04% | -2.6% |
| Q3 2013 | $279,000 | – | 5,567 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |